Any references to wound-related, inflammatory, vascular, skin, or structural pathways are provided only for research context and do not imply therapeutic, cosmetic, or clinical use
FDA approval summary: mylotarg for treatment of patients with relapsed or refractory CD33-positive acute myeloid leukemia
Expanding on this, complement components C3 and C5 play a pivotal role in driving VEGF expression, a key factor in the angiogenesis characteristic of AMD [419]
Considering the role of NADPH-fuelled drug metabolism, NAD + -consuming PARP enzymes in DNA repair following chemotherapy, and recent findings around the role of NAD + in reproductive ageing, we sought to test whether supporting NAD + homeostasis could impact female infertility caused by chemotherapy treatment